Dhanuka Agritech Limited (BOM:507717)
India · Delayed Price · Currency is INR 1,643.65
-270.15 (-14.12%)
At close: Aug 1, 2025
Inozyme Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 2,970 | 2,391 | 2,335 | 2,089 | 2,106 | Upgrade |
Depreciation & Amortization | - | 510.68 | 401.63 | 171.9 | 158.53 | 147.41 | Upgrade |
Other Amortization | - | 43.93 | 4.01 | 4.17 | 4.25 | 4.39 | Upgrade |
Loss (Gain) From Sale of Assets | - | -37.8 | -8.94 | -214.62 | -6.24 | -2.28 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 0.07 | 1.33 | 1.95 | - | Upgrade |
Loss (Gain) From Sale of Investments | - | -43.47 | -88.21 | -44.77 | -130.69 | -146.56 | Upgrade |
Provision & Write-off of Bad Debts | - | 10.52 | 16.85 | 13.03 | 23.64 | 35.15 | Upgrade |
Other Operating Activities | - | -153.03 | -163.58 | -193.05 | -80.21 | -1.68 | Upgrade |
Change in Accounts Receivable | - | -1,139 | -89.13 | -578.69 | -407.25 | -2.55 | Upgrade |
Change in Inventory | - | 191.49 | -728.24 | 21.19 | -905.77 | -456.46 | Upgrade |
Change in Accounts Payable | - | -90.17 | -257.38 | 8.85 | 659.05 | -41.75 | Upgrade |
Change in Other Net Operating Assets | - | 364.17 | -133.39 | -162.1 | -363.49 | 669.37 | Upgrade |
Operating Cash Flow | - | 2,627 | 1,345 | 1,362 | 1,043 | 2,311 | Upgrade |
Operating Cash Flow Growth | - | 95.34% | -1.29% | 30.64% | -54.87% | 42.56% | Upgrade |
Capital Expenditures | - | -1,940 | -893.38 | -1,242 | -598.22 | -126.17 | Upgrade |
Sale of Property, Plant & Equipment | - | 48.45 | 12.77 | 242.53 | 16.59 | 3.62 | Upgrade |
Investment in Securities | - | 123.27 | 126.65 | 869.56 | -362.74 | -1,160 | Upgrade |
Other Investing Activities | - | 221.12 | 189.55 | 148.17 | 128.36 | 156.15 | Upgrade |
Investing Cash Flow | - | -1,427 | -808.93 | 25.65 | -426.01 | -1,266 | Upgrade |
Short-Term Debt Issued | - | 417.12 | - | 28.46 | - | 3.74 | Upgrade |
Total Debt Issued | - | 417.12 | - | 28.46 | - | 3.74 | Upgrade |
Short-Term Debt Repaid | - | - | -33.4 | - | -73.96 | - | Upgrade |
Long-Term Debt Repaid | - | -49.58 | -45.37 | -38.18 | -36.23 | -34.89 | Upgrade |
Total Debt Repaid | - | -49.58 | -78.77 | -38.18 | -110.19 | -34.89 | Upgrade |
Net Debt Issued (Repaid) | - | 367.54 | -78.77 | -9.72 | -110.19 | -31.15 | Upgrade |
Repurchase of Common Stock | - | -1,000 | - | -850 | - | -1,232 | Upgrade |
Common Dividends Paid | - | -273.47 | -455.78 | -279.47 | -465.78 | - | Upgrade |
Other Financing Activities | - | -292.9 | -30.87 | -228.73 | -32.03 | -26.94 | Upgrade |
Financing Cash Flow | - | -1,199 | -565.42 | -1,368 | -608 | -1,291 | Upgrade |
Net Cash Flow | - | 0.61 | -29.74 | 19.98 | 8.71 | -246.12 | Upgrade |
Free Cash Flow | - | 686.61 | 451.24 | 120.5 | 444.51 | 2,184 | Upgrade |
Free Cash Flow Growth | - | 52.16% | 274.48% | -72.89% | -79.65% | 47.24% | Upgrade |
Free Cash Flow Margin | - | 3.37% | 2.57% | 0.71% | 3.01% | 15.74% | Upgrade |
Free Cash Flow Per Share | - | 15.16 | 9.90 | 2.60 | 9.54 | 46.28 | Upgrade |
Cash Interest Paid | - | 51.12 | 30.87 | 31.18 | 32.03 | 26.94 | Upgrade |
Cash Income Tax Paid | - | 946.78 | 794.23 | 732.53 | 659.62 | 610.37 | Upgrade |
Levered Free Cash Flow | - | 411.11 | -440.63 | 90.33 | 589.96 | 1,475 | Upgrade |
Unlevered Free Cash Flow | - | 443.05 | -421.34 | 109.82 | 609.98 | 1,491 | Upgrade |
Change in Net Working Capital | - | 434.73 | 1,730 | 496.02 | 509.5 | 121.34 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.